GlycA (Glycoprotein Acetylation)
GlycA is a composite inflammatory biomarker measured by nuclear magnetic resonance (NMR) spectroscopy. The signal arises from sugar (N-acetyl) groups on several circulating acute-phase glycoproteins, so a single GlycA value integrates the activity of multiple inflammatory proteins at once. Because it reflects chronic, low-grade systemic inflammation rather than a single acute spike, a longevity practice uses GlycA as a stable readout of "inflammaging" and residual cardiovascular and mortality risk.
What It Measures
A composite NMR signal from N-acetyl groups on acute-phase glycoproteins; an integrated index of chronic systemic (low-grade) inflammation.
Optimal vs. Lab Range
Target range for optimal health and longevity based on research.
Population-based reference range from standard labs.
Why It Matters
Unlike hs-CRP, which can swing with transient infections, GlycA integrates several acute-phase proteins and tends to be more stable over time, making it a useful marker of chronic inflammatory burden. In the Women's Health Study (~27,500 women), each standard-deviation increase in GlycA was associated with higher all-cause mortality (hazard ratio ~1.14). A post hoc analysis of the AIM-HIGH trial found baseline GlycA associated with future cardiovascular events and all-cause mortality even in patients treated to low LDL-C, consistent with GlycA capturing residual inflammatory risk. Higher GlycA has been linked to cardiovascular disease, type 2 diabetes, and several inflammation-related conditions. As an emerging marker it complements — rather than replaces — hs-CRP, and values are interpreted in the context of the specific NMR assay used.
When Low
Lower GlycA reflects low chronic inflammatory burden and is associated with lower cardiovascular and mortality risk.
When Optimal
Values in the lower portion of the assay's population range indicate low systemic inflammation; lower is generally better.
When High
Elevated GlycA reflects higher chronic inflammatory burden and has been associated with increased risk of cardiovascular disease, type 2 diabetes, and all-cause mortality. Persistent elevation warrants evaluation of lifestyle, metabolic, and autoimmune contributors.
How to Optimize
Because GlycA tracks chronic inflammation, the levers are the familiar anti-inflammatory fundamentals: a whole-food, fiber-rich dietary pattern, regular physical activity, achieving a healthy body composition, adequate sleep, smoking cessation, and management of metabolic markers such as insulin, HbA1c, and ApoB. Treating underlying inflammatory or autoimmune conditions lowers GlycA as disease activity improves. Interpret GlycA alongside hs-CRP and retest to confirm a trend rather than a single value. This content is educational and not a substitute for medical advice.
Key Interventions & Linked Compounds
Emerging evidenceKey Interventions
Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.
Ordering Notes
Specimen
NMR spectroscopy (serum/plasma)
Patient prep
No fasting required. Maintain usual diet and medications unless advised.
Recommended cadence
Annual, or when tracking systemic inflammation
Reporting unit
µmol/L
Pre-analytic notes
Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.
Recommended Follow-Up Actions
- 1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift GlycA (Glycoprotein Acetylation).
- 2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
- 3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
- 4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
- 5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.
Testing Information
Recommended Frequency
Annual, or when tracking systemic inflammation
Fasting Requirement
No fasting required
Available Test Types
Quick Actions
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation